BeStock  
Stocks › Biotechnology › ACRS

Aclaris Therapeutics ACRS

US equityMarket cap rank #3543Biotechnology
$3.44 −$0.06 (-1.71%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $3.44 0.00%
Open$3.44
Prev close$3.50
Day range$3.40 – $3.55
Volume2.19M
Market cap$545.63M
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts7
Average target$11.71+240.4% vs. price
  • Buy 100%
Low $8.00Now $3.44Avg $11.71High $16.00

Recent rating changes

The last 20 actions on file set price targets from $8.00 to $16.00, averaging $12.25.

DateFirmRatingTarget
9 Nov 2026 H.C. Wainwright BUY $16.00
6 Nov 2026 CCORF BUY $13.00
6 Nov 2026 Wedbush BUY $8.00
30 Oct 2026 CCORF BUY $13.00
28 Oct 2026 Craig-Hallum BUY $9.00
28 Oct 2026 Guggenheim BUY $12.00
28 Oct 2026 H.C. Wainwright BUY $16.00
19 Oct 2026 Piper Sandler BUY $11.00
7 Oct 2026 Piper Sandler BUY $11.00
1 Oct 2026 LifeSci Capital BUY $13.00
1 Sep 2026 CCORF BUY $10.00
31 Aug 2026 Piper Sandler BUY $11.00
10 Aug 2026 H.C. Wainwright BUY $16.00
7 Aug 2026 Piper Sandler BUY $11.00
6 Aug 2026 LifeSci Capital BUY $13.00
6 Aug 2026 Craig-Hallum BUY $10.00
17 Jul 2026 Piper Sandler BUY $11.00
1 Jun 2026 LifeSci Capital BUY $13.00
11 May 2026 Guggenheim BUY $12.00
11 May 2026 H.C. Wainwright BUY $16.00

Discussion

No comments yet — be the first to weigh in on ACRS.

Sign in to join the discussion.

Scroll to Top